Fosun Pharma Controls Heparin API Maker Sainuo; Solely Sells Albiomin
This article was originally published in PharmAsia News
Executive Summary
Jiangsu Wanbang Biochemical Pharmaceuticals Co., Ltd., Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s subsidiary, has signed an agreement with Zaozhuang Ruicheng Biochemical Co., Ltd. for Ruicheng’s 51% stake in domestic heparin API producer Zaozhuang Sainuo Kang Biochemical Co., Ltd.